Navigation Links
H1N1 Flu Vaccine Safe for Expectant Moms, Offspring: Study
Date:7/10/2012

By Serena Gordon
HealthDay Reporter

TUESDAY, July 10 (HealthDay News) -- Although hastily created in response to the pandemic threat posed by the H1N1 flu virus, the vaccine for H1N1 is safe, even for expectant mothers and their babies, new studies show.

A Danish study that included more than 53,000 pregnant women, 13 percent of whom received the H1N1 vaccine, found no increased risk of major birth defects or pregnancy problems.

"We compared the vaccinated with the unvaccinated pregnancies with respect to a number of adverse events -- major birth defects, premature birth and fetal growth problems. None of these adverse events were more common among H1N1-vaccinated pregnancies. We conclude that H1N1-vaccinated pregnancies are not at increased risk of these adverse events," said Dr. Anders Hviid, a senior investigator at Statens Serum Institut, in Copenhagen.

Results of the study are published in the July 11 issue of the Journal of the American Medical Association.

The first case of H1N1 influenza was diagnosed in the United States in April 2009. This new flu was declared a pandemic flu in mid-June 2009. By mid-October, health officials had created and manufactured enough H1N1 vaccine to begin immunizing people at highest risk of complications and death from H1N1. By December 2009, the vaccine was widely available.

Pregnant women were among the high-priority groups, but safety data on the potential effects on fetuses were limited. However, the risks of contracting H1N1 during pregnancy were considered more severe, and the benefits of the vaccine appeared to outweigh any potential risk. More than 2.4 million American women were vaccinated against H1N1, according to the study.

In the current study, no difference in birth weights was detected among babies whose moms got the H1N1 vaccine during pregnancy and no increase in major birth defects was apparent in babies up to 1 year, the authors said.

Hviid noted that while this study adds to the literature on the safety of influenza vaccines in pregnancy, it isn't a complete evaluation of vaccines in pregnancy. "We cannot recommend specific courses of action based only on our study. However, our results are certainly reassuring to pregnant women and medical professionals," Hviid said.

Also, while the data on vaccination in the second and third trimesters provides "robust evidence of safety," the authors said the findings on first-trimester vaccination are considered preliminary and need confirmation.

Dr. John Treanor, chief of the infectious diseases division at the University of Rochester Medical Center, in New York, said, "This is one more bit of info about the safety of vaccinations in pregnancy. There were many, many concerns at the time about potential side effects, but we didn't see them." He added, "The one thing we do have to get better at is getting it out to people early enough. We weren't ready with the vaccine in the States until the second wave of the pandemic."

Another study in the same issue of the journal found that while the risk of Guillain-Barre syndrome, a neurological condition that leads to weakness and loss of reflexes, was slightly increased after H1N1 vaccination, the risk was approximately two cases per 1 million doses.

There was significant concern when the H1N1 vaccine was in development because of an unusually high number of cases of Guillain-Barre in 1976 and 1977 following administration of the swine flu vaccine. Since that time, there hasn't been a significant risk associated with Guillain-Barre and the seasonal flu vaccine.

Between October 2009 and March 2010 in Quebec, Canada, 4.4 million people received the new H1N1 vaccine. During that time, 83 people in the whole population developed Guillain-Barre. Twenty-five of those had been vaccinated for H1N1 in the previous eight weeks, and 19 of the 25 had been vaccinated in the previous four weeks. That translated to a risk of about 2 cases of Guillain-Barre for every 1 million doses of vaccine. The risk was only seen in people older than 50, according to the study.

"In Quebec, the 2009 influenza A (H1N1) vaccine was associated with a small, but significant risk of [Guillain-Barre syndrome]. It is likely that the benefits of immunization outweigh the risks," wrote study authors Dr. Philippe De Wals of Laval University, in Quebec City, and colleagues.

Treanor said it's almost impossible to know for sure if the vaccine caused the additional cases of Guillain-Barre, but emphasized that the individual risk is "very, very small."

More information

Learn more about the flu and the seasonal vaccine from the U.S. Centers for Disease Control and Prevention.

SOURCES: Anders Hviid, M.Sc., Dr.Med.Sci., senior investigator, Statens Serum Institut, Copenhagen; John Treanor, M.D., chief, infectious diseases division, University of Rochester Medical Center, N.Y.; July 11, 2012, Journal of the American Medical Association


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Young girls more likely to report side effects after HPV vaccine
3. Preteens More Likely to Report HPV Vaccine Side Effects
4. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
5. Early Study Finds Some Promise for Lung Cancer Vaccine
6. From a Failed Vaccine, New Insights Into Fighting HIV
7. From herd immunity and complacency to group panic: How vaccine scares unfold
8. Brain Tumor Vaccine Shows Promise in Early Trial
9. Army researcher develops potential vaccine carrier
10. A physicians guide for anti-vaccine parents
11. Shingles Vaccine Safe, Underutilized, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
H1N1 Flu Vaccine Safe for Expectant Moms, Offspring: Study
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: